top of page

Pfizer and BioNTech Seek FDA Nod For COVID Booster Shot For Children



On Monday, Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) announced that they have submitted an Emergency Use Authorization EUA request to the FDA for a 10 -µg booster dose of its Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for children ages 5 through 11 years of age. Nice!



Photo Credit: Artur Aldyrkhanov

 
 
 

Comments


Thanks for submitting!

Stay updated on the latest good newz!

GoodNewzUniversal brings the top positive news about the world, daily. No matter what happens, there is always going to be good news all over the world. This website has assembled it, just for you.

    © 2023 BY ARYAMAN SINHA

    bottom of page